This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“What should my bloodpressure be?” The problem is that high bloodpressure is not some obscure risk that only impacts a small percentage of the population. The problem is that high bloodpressure is not some obscure risk that only impacts a small percentage of the population.
However, it remains unclear which type of exercise is most effective for managing AS, particularly in individuals at high risk for cardiovasculardiseases (CVD). BackgroundPrevious studies have shown that exercise can improve arterial stiffness (AS).
partially because its key risk factor, high bloodpressure, is a ‘silent killer,’ and most patients have no symptoms before their first heart attack or stroke. The monitor and app recorded bloodpressure, heart rate, and the appearance of irregular heartbeat. Eighty percent of heart attacks and strokes are preventable.
The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or high bloodpressure, in older adults without increasing their risk of low bloodpressure episodes, according to a study published in the Feb. 2024 issue of the Journal of the American College of Cardiology (JACC).
Abstract Background Existing data on the association between bloodpressure levels and adverse cardiovascularoutcomes in patients with heart failure (HF) are inconsistent. The optimal bloodpressure targets for patients with HF remain uncertain.
Getty Images milla1cf Fri, 06/28/2024 - 08:10 June 27, 2024 — Cardiovasculardisease is the leading cause of death for women, and gaps in care and access persist between women and men. Similarly, cardiovascular research and clinical studies often underrepresent women, resulting in subpar treatment outcomes.
Other studies have also unearthed more intricate connections which suggests that physiological conditions, underpinned by biological and chemical factors, may also play a pivotal role in influencing cardiovasculardisease (CVD). In 2021 alone, CVD accounted for over 900,000 deaths in the U.S. and approximately 19.91 million globally.
Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovasculardiseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries. Impaired Healing and Recovery Nicotine constricts blood vessels, reducing blood flow to surgical sites.
A projected rise in heart disease and stroke – along with several key risk factors, including high bloodpressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovasculardisease within the next 30 years, according to two new science reports. and Susan F. population.
Take a 40-year-old male who is overweight but not obese, has a systolic bloodpressure of 135 mmHg and an LDL cholesterol of 4.1 mmol/l (158 mg/dl), is a non-smoker and has a family history of heart disease. Sign Me Up 1 2022: The Year in CardiovascularDisease – The Year of Upfront Lipid Lowering Combination Therapy.
Atherosclerotic cardiovasculardisease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
Recent consensus statements combine an increase in bloodpressure upon standing with standing hypertension, but whether these 2 components have similar risk associations with cardiovasculardisease (CVD) is unknown.METHODS:The ARIC study (Atherosclerosis Risk in Communities) measured supine and standing bloodpressure during visit 1 (19871989).
The relationship between ankle bloodpressure (BP) and cardiovasculardisease remains unclear. We examined the relationships between known and new ankle BP indices and major cardiovascularoutcomes in people w.
Background The COVID-19 pandemic disrupted cardiovasculardisease management in primary care in England. Results The percentage of patients aged ≥45 years who had bloodpressure screening recorded in the preceding 5 years decreased from 90% (March 2019) to 85% (March 2023).
Introduction Compared with first-line antihypertensives, beta-blockers (BB) have been reported to lower the central aortic bloodpressure suboptimally and are associated with increased stroke risk. Second- or third-generation beta-blockers reduced the mean arterial pressure by 1.75 mmHg [95% confidence interval (CI):1.16–2.33;
A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in bloodpressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. Of 102,475 participants, 49.1% were female.
It found that targeting bloodpressure below 130/80 mm Hg could sustainably reduce cardiovasculardisease incidence by 25% and total mortality by 10%. Given frailtys impact on bloodpressure and adverse health outcomes, its evaluation is essential for effective hypertension management in older adults.
Adverse pregnancy outcomes are common among pregnant individuals and are associated with long-term risk of cardiovasculardisease. Individuals with adverse pregnancy outcomes also have an increased incidence of cardiovasculardisease risk factors after delivery.
BACKGROUND:The STEP (Strategy of BloodPressure Intervention in the Elderly Hypertensive Patients) trial demonstrated that intensive systolic bloodpressure (SBP) lowering has cardiovascular benefits. years, and 46.5% years, and 46.5%
The primary outcome of major adverse cardiovascular events included stroke, myocardial infarction, heart failure, and death from cardiovascular causes, during a 3year followup.
Primordial prevention is changing the environment around you so you do not develop the risk factors for heart disease and, by extension, do not get the disease early in life. BloodPressure Control High bloodpressure is the risk factor associated with the greatest number of deaths worldwide. N Engl J Med.
BACKGROUND:Adverse pregnancy outcomes (APOs) share clinical features and risk factors with cardiovasculardisease and there is an increasing prevalence of hypertension among reproductive women. The primary outcome was a composite of APOs, including preterm birth, small for gestational age, and perinatal infant death.
The precise mechanisms of bloodpressure (BP) regulation are not fully elucidated, and understanding BP regulation is crucial for managing hypertension and improving outcomes for cardiovasculardisease. In this issue of the JCI, Wang et al.
milla1cf Fri, 06/28/2024 - 19:07 June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa , its flagship health equity initiative, to target a broader range of non-communicable diseases (NCDs), including chronic kidney disease (CKD) as well as hypertension and cardiovasculardisease.
High bloodpressure causes over 10 million preventable deaths annually globally. Populations in low- and middle-income countries suffer the most, experiencing increased uncontrolled bloodpressure and cardiovasculardisease (CVD) deaths. Hypertension, Ahead of Print.
HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. “We It’s an honor to have the U.S.’s
Introduction Hypertension is the leading modifiable risk factor for cardiovasculardisease and is implicated in half of all strokes and myocardial infarctions. One-third of the adults in Scotland have hypertension yet only a quarter of them have their bloodpressure (BP) controlled to target (<140/90 mm Hg).
The poor folks who ate all their meals within shorter time frames on the days before those two particular surveys had far worse outcomes over the 8-year median follow-up period. People who ate within an eight hour window had a 91% higher risk of death due to cardiovasculardisease.
Somers, MD, PhD , a consultant in cardiovascular medicine from the Mayo Clinic, discusses how sleep impacts both cardiovascular and metabolic outcomes. Bloodpressure increases : Both daytime and nighttime bloodpressure rise with sleep deprivation, particularly in women, heightening cardiovascular risk.
Similar patterns have been observed for cardiovasculardisease and also cancer. Less major diseases earlier in life. Less gastroesophageal reflux disease. Less high bloodpressure. Even 30 minutes per day has been shown to improve health outcomes 6. Taking 12,000-a-day steps led to a 65% reduction 5.
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
BACKGROUNDElevated bloodpressure (BP) is associated with increased risk of cardiovascular mortality. However, there is ongoing debate whether intensive BP lowering may paradoxically increase the risk of cardiovasculardisease (CVD), especially in patients with type 2 diabetes (T2D).
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).
Background:Long term follow-up data on elevated bloodpressure (BP) or antihypertensive drugs in young adults are scarce. The primary outcome was a composite of the incidence of myocardial infarction and ischemic and hemorrhagic stroke, obtained by tracking the medical use data of the first-ever ICD-10 codes.
Homophobia affects the mental health of the growing San Joaquin Valley (SJV) LGBTQ+ community leading to psychological distress and mental health concerns which can further lead to High BloodPressure (HBP) and cardiovasculardisease (CVD).
There are numerous effective medications for modifying CAD but new pharmacologic therapies require increasingly large and expensive cardiovascularoutcome trials to assess their potential impact on MACE and to obtain regulatory approval. For many disease areas, nearly a half of drugs are approved by the U.S.
Regardless of what is driving the effect, it is clear that experiencing high levels of stress is associated with worse outcomes. Receiving a cancer diagnosis is associated with a more than five-fold increased risk of a cardiovascular event 5. But why does stress cause more cardiovascular events? Increased clotting.
Environmental toxicants and pollutants are causes of adverse health consequences, including well-established associations between environmental exposures and cardiovasculardiseases. Emerging evidence suggests that environmental exposures in early life may be key risk factors for cardiovascular conditions across the life span.
Insulin resistance and diabetes may not ‘ cause ’ coronary artery disease, but they are huge accelerants. In fact, when considering the contribution of risk for cardiovasculardisease, diabetes and its early manifestations, such as metabolic syndrome and insulin resistance, are some of the biggest drivers of risk.
I do this for three reasons: There is a relationship between short sleep and worse cardiovascularoutcomes. Poor sleep generally impacts cognitive well-being, nutrition and exercise routines, all of which are key pillars of cardiovascular health. Prevalence estimates of sleep apnea in several cardiovascular conditions.
Introduction:Blood pressure targets for the elderly are still controversial, there is a lack of certainty about the benefit and safety of targeting ≤ 130mmHg systolic bloodpressure. of patients had cardiovasculardisease, 10.9% chronic kidney disease. diabetes, and 15.5% and I2 = 0%, p = 0.44).
BackgroundDespite reducing cardiovasculardisease (CVD) events and death in SPRINT (Systolic BloodPressure Intervention Trial), intensive systolic bloodpressure goals have not been adopted in the United States. Journal of the American Heart Association, Ahead of Print.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Outcomes were stratified between groups and tested for significance using a generalized linear mixed-effects model. A 15.5% ([95% CI, 6.2%–24.8%]P=0.004) Sixty-one percent versus 48.2% 95% CI, −6.1
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content